skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:059809/0557   Pages: 6
Recorded: 04/27/2022
Attorney Dkt #:5851.0010-000
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 39
1
Patent #:
Issue Dt:
12/02/2014
Application #:
13436910
Filing Dt:
03/31/2012
Publication #:
Pub Dt:
11/08/2012
Title:
SUBSTITUTED N-PHENYLPYRIMIDIN-2-AMINE ANALOGS AS INHIBITORS OF THE AXL KINASE
2
Patent #:
Issue Dt:
07/19/2016
Application #:
14435976
Filing Dt:
04/15/2015
Publication #:
Pub Dt:
12/03/2015
Title:
PKM2 MODULATORS AND METHODS FOR THEIR USE
3
Patent #:
Issue Dt:
02/27/2018
Application #:
15134051
Filing Dt:
04/20/2016
Publication #:
Pub Dt:
10/20/2016
Title:
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
4
Patent #:
Issue Dt:
09/12/2017
Application #:
15158206
Filing Dt:
05/18/2016
Publication #:
Pub Dt:
11/24/2016
Title:
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
5
Patent #:
Issue Dt:
02/19/2019
Application #:
15183581
Filing Dt:
06/15/2016
Publication #:
Pub Dt:
01/19/2017
Title:
PKM2 MODULATORS AND METHODS FOR THEIR USE
6
Patent #:
Issue Dt:
04/16/2019
Application #:
15673213
Filing Dt:
08/09/2017
Publication #:
Pub Dt:
11/23/2017
Title:
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
7
Patent #:
Issue Dt:
02/25/2020
Application #:
15750151
Filing Dt:
02/02/2018
Publication #:
Pub Dt:
09/13/2018
Title:
COMBINATION THERAPIES FOR TREATMENT OF CANCER
8
Patent #:
Issue Dt:
11/20/2018
Application #:
15847697
Filing Dt:
12/19/2017
Publication #:
Pub Dt:
06/21/2018
Title:
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
9
Patent #:
Issue Dt:
04/23/2019
Application #:
16023360
Filing Dt:
06/29/2018
Publication #:
Pub Dt:
10/18/2018
Title:
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
10
Patent #:
Issue Dt:
07/23/2019
Application #:
16132270
Filing Dt:
09/14/2018
Publication #:
Pub Dt:
01/31/2019
Title:
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
11
Patent #:
Issue Dt:
11/12/2019
Application #:
16226599
Filing Dt:
12/19/2018
Publication #:
Pub Dt:
04/25/2019
Title:
PKM2 MODULATORS AND METHODS FOR THEIR USE
12
Patent #:
Issue Dt:
09/24/2019
Application #:
16279623
Filing Dt:
02/19/2019
Publication #:
Pub Dt:
06/13/2019
Title:
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
13
Patent #:
Issue Dt:
02/18/2020
Application #:
16279958
Filing Dt:
02/19/2019
Publication #:
Pub Dt:
06/13/2019
Title:
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
14
Patent #:
Issue Dt:
05/25/2021
Application #:
16376452
Filing Dt:
04/05/2019
Title:
AXL KINASE INHIBITORS AND USE OF THE SAME
15
Patent #:
Issue Dt:
04/21/2020
Application #:
16425826
Filing Dt:
05/29/2019
Publication #:
Pub Dt:
09/19/2019
Title:
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
16
Patent #:
Issue Dt:
03/22/2022
Application #:
16462094
Filing Dt:
05/17/2019
Publication #:
Pub Dt:
02/13/2020
Title:
ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS
17
Patent #:
Issue Dt:
09/08/2020
Application #:
16584912
Filing Dt:
09/26/2019
Publication #:
Pub Dt:
04/09/2020
Title:
PKM2 MODULATORS AND METHODS FOR THEIR USE
18
Patent #:
Issue Dt:
11/15/2022
Application #:
16646853
Filing Dt:
03/12/2020
Publication #:
Pub Dt:
09/03/2020
Title:
TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 INHIBITOR ALVOCIDIB
19
Patent #:
Issue Dt:
06/16/2020
Application #:
16665277
Filing Dt:
10/28/2019
Publication #:
Pub Dt:
02/20/2020
Title:
COMBINATION THERAPIES FOR TREATMENT OF CANCER
20
Patent #:
Issue Dt:
06/15/2021
Application #:
16703773
Filing Dt:
12/04/2019
Publication #:
Pub Dt:
08/13/2020
Title:
CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATMENT OF CANCER
21
Patent #:
NONE
Issue Dt:
Application #:
16730810
Filing Dt:
12/30/2019
Publication #:
Pub Dt:
10/08/2020
Title:
METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS
22
Patent #:
NONE
Issue Dt:
Application #:
16755868
Filing Dt:
04/13/2020
Publication #:
Pub Dt:
07/30/2020
Title:
PKM2 ACTIVATORS IN COMBINATION WITH REACTIVE OXYGEN SPECIES FOR TREATMENT OF CANCER
23
Patent #:
Issue Dt:
11/17/2020
Application #:
16821762
Filing Dt:
03/17/2020
Publication #:
Pub Dt:
07/09/2020
Title:
COMBINATION THERAPIES FOR TREATMENT OF CANCER
24
Patent #:
Issue Dt:
08/01/2023
Application #:
16826131
Filing Dt:
03/20/2020
Publication #:
Pub Dt:
09/24/2020
Title:
COMPOSITIONS COMPRISING PKM2 MODULATORS AND METHODS OF TREATMENT USING THE SAME
25
Patent #:
Issue Dt:
12/20/2022
Application #:
16919853
Filing Dt:
07/02/2020
Publication #:
Pub Dt:
01/07/2021
Title:
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
26
Patent #:
NONE
Issue Dt:
Application #:
16930254
Filing Dt:
07/15/2020
Publication #:
Pub Dt:
01/07/2021
Title:
PKM2 MODULATORS AND METHODS FOR THEIR USE
27
Patent #:
NONE
Issue Dt:
Application #:
17045411
Filing Dt:
10/05/2020
Publication #:
Pub Dt:
05/20/2021
Title:
MATERIALS AND METHODS FOR TREATING CANCER
28
Patent #:
NONE
Issue Dt:
Application #:
17061821
Filing Dt:
10/02/2020
Publication #:
Pub Dt:
07/29/2021
Title:
COMBINATION THERAPIES FOR TREATMENT OF CANCER
29
Patent #:
Issue Dt:
08/02/2022
Application #:
17092521
Filing Dt:
11/09/2020
Publication #:
Pub Dt:
07/08/2021
Title:
AXL KINASE INHIBITORS AND USE OF THE SAME
30
Patent #:
Issue Dt:
12/20/2022
Application #:
17225836
Filing Dt:
04/08/2021
Publication #:
Pub Dt:
10/28/2021
Title:
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
31
Patent #:
NONE
Issue Dt:
Application #:
17253603
Filing Dt:
12/17/2020
Publication #:
Pub Dt:
09/09/2021
Title:
DEUTERATED ALVOCIDIB AND ALVOCIDIB PRODRUGS
32
Patent #:
NONE
Issue Dt:
Application #:
17284409
Filing Dt:
04/09/2021
Publication #:
Pub Dt:
12/09/2021
Title:
METHODS FOR MONITORING TUMOR LYSIS SYNDROME
33
Patent #:
NONE
Issue Dt:
Application #:
17314896
Filing Dt:
05/07/2021
Publication #:
Pub Dt:
08/26/2021
Title:
Alvocidib Prodrugs Having Increased Bioavailability
34
Patent #:
Issue Dt:
10/24/2023
Application #:
17435264
Filing Dt:
08/31/2021
Publication #:
Pub Dt:
04/28/2022
Title:
Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure
35
Patent #:
NONE
Issue Dt:
Application #:
17439611
Filing Dt:
09/15/2021
Publication #:
Pub Dt:
05/26/2022
Title:
PKM2 MODULATORS AND METHODS FOR THEIR USE
36
Patent #:
NONE
Issue Dt:
Application #:
17547799
Filing Dt:
12/10/2021
Publication #:
Pub Dt:
10/27/2022
Title:
METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE PROSTATE CANCER
37
Patent #:
NONE
Issue Dt:
Application #:
17596805
Filing Dt:
12/17/2021
Publication #:
Pub Dt:
09/29/2022
Title:
Treatment of Cancer
38
Patent #:
NONE
Issue Dt:
Application #:
17596807
Filing Dt:
12/17/2021
Publication #:
Pub Dt:
08/18/2022
Title:
Treatment of Cancer
39
Patent #:
NONE
Issue Dt:
Application #:
17761993
Filing Dt:
03/18/2022
Publication #:
Pub Dt:
12/01/2022
Title:
AXL INHIBITOR FORMULATIONS
Assignor
1
Exec Dt:
04/01/2022
Assignee
1
640 MEMORIAL DRIVE
CAMBRIDGE, MASSACHUSETTS 02139
Correspondence name and address
ERIC M. BALICKY, PH.D.
530 VIRGINIA ROAD, PO BOX 9133
HAMILTON, BROOK, SMITH & REYNOLDS, P.C.
CONCORD, MA 01742

Search Results as of: 04/27/2024 08:49 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT